Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients with Myelodysplastic Syndromes from the Argentine Database

In our retrospective review of 831 patients, 158 progressed with a very poor outcome (median survival after evolution: 3.5 months). The survival of patients with adverse karyotypes or with higher IPSS-R or WPSS risk was not affected upon comparison of patients with or without evolution to AML. Our results may help individualizing those patients that would require a more aggressive treatment.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Tags: Original Study Source Type: research